Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | OGG1 | O15527 | 1/20 | 0.30 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21398901 | 0.94 | ALOX5 (0.32) | MCL1MAPK1ALOX5 | |
| SCHEMBL21398642 | 0.88 | MAPT (0.32) | MCL1MAPK1MEN1ALDH1A1MAPT | |
| SCHEMBL22925204 | 0.86 | — | — | |
| SCHEMBL21281887 | 0.86 | MCL1 (0.39) | MCL1MAPK1MEN1ALDH1A1MAPT | |
| SCHEMBL22925293 | 0.83 | CYP1A2 (0.32) | MCL1ALDH1A1MAPT | |
| SCHEMBL15852730 | 0.81 | — | — | |
| SCHEMBL22505851 | 0.81 | TOP1 (0.30) | — | |
| SCHEMBL15852508 | 0.81 | GPR3 (0.42) | MEN1ALDH1A1MAPTKMT2AALOX5 | |
| SCHEMBL21398774 | 0.80 | MCL1 (0.35) | MCL1MAPK1MEN1ALDH1A1MAPT | |
| SCHEMBL21398832 | 0.80 | MAPT (0.37) | MCL1MAPK1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210028370-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREFOR | DUK SAN NEOLUX CO., LTD. (KR) | 2021-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210028370-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREFOR | OR51E2, WEE1, SLC39A11 | MCL1 2060/4885MAPK1 2168/4885MEN1 547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.